Trial intelligence / Profile preview

Azithromycin vs Sulphadoxine-pyrimethamine for Malaria Prophylaxis in Pregnant HIV+ Women

NCT02527005Phase 1Completed

Start
Sep 2015
Primary completion
Aug 2016
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, randomised, single-blind trial of azithromycin in malaria (2 arms). Primary endpoint: Level of malaria parasitemia at delivery. Started Sep 2015; status: completed.

02

Drugs

azithromycin
03

Conditions

malaria

Beyond the preview

Go deeper on NCT02527005.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02527005.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call